These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 2407778

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis.
    Flynn JT, Frisch K, Kershaw DB, Sedman AB, Bunchman TE.
    Adv Perit Dial; 1999; 15():269-72. PubMed ID: 10682116
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.
    Deforest A, Long SS, Lischner HW, Girone JA, Clark JL, Srinivasan R, Maguire TG, Diamond SA, Schiller RP, Rothstein EP.
    Pediatrics; 1988 Feb; 81(2):237-46. PubMed ID: 3340474
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE, Buynak EB, Stokes J, Hilleman MR.
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract] [Full Text] [Related]

  • 29. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, Hesketh L, Brown D, Tookey P, Peckham C.
    Commun Dis Rep CDR Rev; 1997 Feb 07; 7(2):R26-32. PubMed ID: 9046126
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T, Baer M, Willems P.
    Pediatr Infect Dis J; 2007 Feb 07; 26(2):153-8. PubMed ID: 17259879
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Vaccination status and implementation of recommendations for vaccination with special reference to measles-mumps-rubella vaccination. 1995 program for school entrance].
    Ziemer B, Blank K, Hennig R.
    Gesundheitswesen; 1998 May 07; 60(5):297-300. PubMed ID: 9676011
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Measles mumps rubella (MMR) vaccine in Japan.
    Kuno-Sakai H, Kimura M.
    Acta Paediatr Jpn; 1988 Apr 07; 30(2):167-74. PubMed ID: 3149851
    [No Abstract] [Full Text] [Related]

  • 40. Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines.
    Weibel RE, Buynak EB, McLean AA, Hilleman MR.
    Pediatrics; 1975 Sep 07; 56(3):380-7. PubMed ID: 1161394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.